ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,636Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 51

$1.3M Total Retail Price of All Prescriptions

Rank: 7 out of 51

730 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 730 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

44% of this provider’s 730 patients filled at least one prescription for a schedule three drug, compared to an average of 27%.

Risky Drugs to Seniors

3% of this provider’s 15,928 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,606 804 S3 1 1
OMEPRAZOLE 642 458 2 3
FUROSEMIDE 597 455 3 2
SIMVASTATIN 529 370 4 4
LISINOPRIL 487 400 5 7
METFORMIN HCL 435 303 6 9
GABAPENTIN 408 208 7 12
TRAZODONE HCL 406 285 8 23
POTASSIUM CHLORIDE 397 294 9 8
LEVOTHYROXINE SODIUM 375 266 10 6
AMLODIPINE BESYLATE 366 248 11 5
HYDROCHLOROTHIAZIDE 365 316 12 15
WARFARIN SODIUM 355 294 13 11
CITALOPRAM HBR 336 268 14 18
CARVEDILOL 327 236 15 13
RISPERIDONE 320 253 16 27
TRAMADOL HCL 299 193 17 10
NAMENDA 279 265 18 16
DONEPEZIL HCL 268 242 19 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 236 157 20 35
MELOXICAM 228 139 21 20
METOPROLOL TARTRATE 225 172 22 14
TAMSULOSIN HCL 225 158 22 36
NEXIUM 219 98 24 24
DIVALPROEX SODIUM 217 151 25 44
PANTOPRAZOLE SODIUM 191 102 26 34
SERTRALINE HCL 190 143 27 32
CYMBALTA 185 63 28 37
BENZTROPINE MESYLATE 183 144 R 29 91
RANITIDINE HCL 182 140 30 28
CLOPIDOGREL 181 131 31 41
ATENOLOL 163 128 32 33
ZOLPIDEM TARTRATE 161 53 33 22
GLIPIZIDE 161 150 33 40
PAROXETINE HCL 159 108 35 69
QUETIAPINE FUMARATE 156 121 36 38
OLANZAPINE 152 108 37 92
DIGOXIN 144 130 38 42
LEVOFLOXACIN 136 90 39 85
EXELON 135 134 40 50
METOPROLOL SUCCINATE 132 81 41 25
CIPROFLOXACIN HCL 127 82 42 48
LYRICA 126 64 43 54
ATORVASTATIN CALCIUM 126 83 43 30
LANTUS 123 79 45 31
SINGULAIR 122 57 46 95
AMOX TR-POTASSIUM CLAVULANATE 122 76 46 182
HYDRALAZINE HCL 118 102 48 52
AMOXICILLIN 109 45 49 157
CLONIDINE HCL 109 74 49 26
METOCLOPRAMIDE HCL 108 85 51 64
PLAVIX 108 80 51 58
LOSARTAN POTASSIUM 107 87 53 29
LAMOTRIGINE 107 38 53 164
PRAVASTATIN SODIUM 107 77 53 19
POLYETHYLENE GLYCOL 3350 104 98 56 45
PROMETHAZINE HCL 103 53 R 57 56
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 55 57 62
CYCLOBENZAPRINE HCL 99 38 R 59 53
ESCITALOPRAM OXALATE 98 57 60 39
METOLAZONE 98 78 60 155
NITROGLYCERIN PATCH 96 82 62 130
VENLAFAXINE HCL 96 73 62 219
PRIMIDONE 96 62 62 139
FLUTICASONE PROPIONATE 92 45 65 51
FLUOXETINE HCL 92 45 65 60
MIRTAZAPINE 92 62 65 21
NOVOLIN R 89 70 68 78
GENTAMICIN SULFATE 88 50 69 198
HUMULIN 70-30 87 41 70 104
HALOPERIDOL 87 51 70 105
NYSTATIN 86 62 72 107
MONTELUKAST SODIUM 86 29 72 146
DILTIAZEM 24HR CD 85 64 74 106
KLOR-CON M20 85 67 74 83
JANUVIA 84 59 76 108
PHENYTOIN SODIUM EXTENDED 84 37 76 84
LEVETIRACETAM 84 31 76 61
LOVASTATIN 81 34 79 123
OXYBUTYNIN CHLORIDE 80 73 80 142
MEGESTROL ACETATE 79 78 R 81 88
ROPINIROLE HCL 78 44 82 75
SUCRALFATE 78 60 82 82
BACLOFEN 78 35 82 113
AMITRIPTYLINE HCL 76 35 R 85 49
ENALAPRIL MALEATE 76 59 85 81
AZITHROMYCIN 73 31 87 47
DICYCLOMINE HCL 72 58 88 177
SPIRIVA 71 47 89 87
ALLOPURINOL 68 45 90 43
AMITIZA 68 55 90 234
ADVAIR DISKUS 68 37 90 72
PREDNISONE 68 48 90 76
HUMULIN R 67 50 94 112
GLIMEPIRIDE 66 37 95 71
NAPROXEN 66 22 95 120
CLARITHROMYCIN 64 30 97 283
BUPROPION HCL SR 63 31 98 235
FENTANYL 62 46 S2 99 65
BUSPIRONE HCL 62 52 99 77
ACTOS 61 30 101 138
VERAPAMIL ER 60 42 102 115
DICLOFENAC SODIUM 59 25 103 217
DOXYCYCLINE HYCLATE 59 27 103 90
RAMIPRIL 57 47 105 73
SEROQUEL 56 37 106 86
ALENDRONATE SODIUM 55 39 107 59
LANTUS SOLOSTAR 53 18 108 224
CARBIDOPA-LEVODOPA 52 50 109 74
DIOVAN HCT 52 20 109 131
ETODOLAC 52 0 109 211
VENLAFAXINE HCL ER 50 26 112 145
TRIAMCINOLONE ACETONIDE 50 31 112 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.